The TB Vaccine Advocacy Roadmap (TB Vax ARM) and Stop TB Partnership Working Group on New TB Vaccines, in collaboration with IAVI, are proud to welcome seven participants for the 2023 TB vaccine advocacy fellowship. The fellows, representing affected community members, advocates, and early career researchers from five different countries, have come together for an online skill-sharing and co-creation program featuring a lineup of workshops led by advocacy experts from around the world to help them hone their skills to develop and contribute to future advocacy campaigns.

Running throughout February and March, the goal of the program is to help cultivate a new generation of TB vaccine R&D advocates and stimulate more diverse advocacy efforts for TB vaccine R&D ahead of the United Nations High-Level Meeting on TB in September 2023 and beyond. Over the course of the fellowship, the budding TB vaccine advocates are also joining forces to develop a collaborative advocacy campaign that will be launched ahead of World TB Day on 24 March.

Meet the fellows

  • Bello Abdussalam, 5th year medical student, Ahmadu Bello University, Zaria, Nigeria
  • Keyuri Bhanushali, fellow, Survivors Against TB, Mumbai, India
  • Mbali Mkhonza, PhD candidate, Stellenbosch University, Cape Town, South Africa
  • Charlton Muchemwa, programme officer at Pangaea Zimbabwe AIDS Trust, Harare, Zimbabwe
  • Joseph Mwaka, head of infectious disease response, Bidibidi refugee camp, Amuru, Uganda
  • Bakul Piplani, molecular microbiologist, Indian Institute of Technology Delhi, New Delhi, India
  • Zethu Sonyoka, MSc candidate, Stellenbosch University, Cape Town, South Africa

Click here to learn more about the fellows


  • Why TB vaccines: the promising science
    David Lewinsohn, Chair, WGNV (Oregon, USA)
  • Funding & advocacy  landscape for TB vaccine R&D
    Erin McConnell, Senior TB Associate, Treatment Action Group (New York, USA)
  • Considerations for grassroots advocacy
    Chapal Mehra, Survivors Against TB (New Delhi, India)
  • Considerations for direct advocacy
    Deborah Ikeh, Francophone & West Africa Regional Manager, Global TB Caucus (Abuja, Nigeria)
  • Researchers as advocates: finding a common ground
    Cheleka Mpande, independent practitioner (Geneva Switzerland)
  • Messaging for impact
    Priyanka Aiyer, Communications Specialist, Global Fund Advocates Network (New Delhi, India)
  • How to run a successful campaign
    Rosemary Mburu, Executive Director, WACI Health (Nairobi, Kenya)

The campaign

Stay tuned to discover the fellows' World TB Day campaign!

Who is the TB Vax ARM?

  • An informal global network of TB advocates
  • Dedicated to mobilizing support and resources for TB vaccine R&D
  • Engaged in political advocacy, including the G20 Open Letter

Visit the Take Action page for more information about the TB Vax ARM.